全文获取类型
收费全文 | 121779篇 |
免费 | 6234篇 |
国内免费 | 1481篇 |
专业分类
耳鼻咽喉 | 149篇 |
儿科学 | 1638篇 |
妇产科学 | 1127篇 |
基础医学 | 8390篇 |
口腔科学 | 410篇 |
临床医学 | 12920篇 |
内科学 | 50340篇 |
皮肤病学 | 311篇 |
神经病学 | 3509篇 |
特种医学 | 4855篇 |
外国民族医学 | 2篇 |
外科学 | 29871篇 |
综合类 | 4826篇 |
现状与发展 | 9篇 |
一般理论 | 5篇 |
预防医学 | 2947篇 |
眼科学 | 391篇 |
药学 | 4783篇 |
34篇 | |
中国医学 | 425篇 |
肿瘤学 | 2552篇 |
出版年
2024年 | 96篇 |
2023年 | 4281篇 |
2022年 | 6085篇 |
2021年 | 7783篇 |
2020年 | 6567篇 |
2019年 | 4240篇 |
2018年 | 4327篇 |
2017年 | 3616篇 |
2016年 | 3583篇 |
2015年 | 3841篇 |
2014年 | 8943篇 |
2013年 | 6784篇 |
2012年 | 6261篇 |
2011年 | 5796篇 |
2010年 | 5776篇 |
2009年 | 5599篇 |
2008年 | 4560篇 |
2007年 | 4716篇 |
2006年 | 4551篇 |
2005年 | 3862篇 |
2004年 | 3519篇 |
2003年 | 3210篇 |
2002年 | 3031篇 |
2001年 | 2780篇 |
2000年 | 2292篇 |
1999年 | 2223篇 |
1998年 | 1179篇 |
1997年 | 830篇 |
1996年 | 798篇 |
1995年 | 712篇 |
1994年 | 584篇 |
1993年 | 439篇 |
1992年 | 948篇 |
1991年 | 887篇 |
1990年 | 850篇 |
1989年 | 576篇 |
1988年 | 596篇 |
1987年 | 285篇 |
1986年 | 120篇 |
1985年 | 223篇 |
1984年 | 268篇 |
1983年 | 253篇 |
1982年 | 207篇 |
1981年 | 178篇 |
1980年 | 160篇 |
1979年 | 159篇 |
1978年 | 185篇 |
1977年 | 92篇 |
1976年 | 100篇 |
1974年 | 87篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
《Journal of diabetes and its complications》2022,36(8):108260
AimTo verify whether arterial stiffness and endothelial dysfunction influence lower limb muscle strength and gait speed in older adults with type 2 diabetes mellitus (T2DM).MethodsCross-sectional study including seventy-eight older adults with T2DM (aged 67 ± 6 years and 42 % male). Arterial stiffness was assessed using pulse wave velocity (PWV), while endothelial function was measured by flow-mediated dilation (FMD). Lower limb muscle strength and gait speed were assessed using the 30-second chair stand test (30s-CST) and 10-Meter Walk Test, respectively.ResultsBoth PWV (m/s) and FMD (%) were univariately associated with number of repetitions in 30s-CST and gait speed (P < 0.05). After control for age, sex and body mass index, PWV remained associated with repetitions in 30s-CST (95 % CI: ?0.494 to ?0.054; P = 0.015) and gait speed (95 % CI: ?0.039 to ?0.002; P = 0.031). After adjustments for control variables, T2DM duration and glycemic control, FMD was associated with repetitions in 30s-CST (95 % CI: 0.008 to 0.324; P = 0.039) and gait speed (95 % CI: 0.011 to 0.038; P = 0.001).ConclusionIn older adults with T2DM, both arterial stiffness and endothelial dysfunction are associated with decreased leg muscle strength and slower gait speed. 相似文献
5.
《The Canadian journal of cardiology》2022,38(10):1558-1566
BackgroundThe increasing availability of large electronic population-based databases offers unique opportunities to conduct cardiovascular health surveillance traditionally done using surveys. We aimed to examine cardiovascular risk-factor burden, preventive care, and disease incidence among adults in Ontario, Canada—using routinely collected data—and compare estimates with health survey data.MethodsIn the Cardiovascular Health in Ambulatory Care Research Team (CANHEART) initiative, multiple health administrative databases were linked to create a population-based cohort of 10.3 million adults without histories of cardiovascular disease. We examined cardiovascular risk-factor burden and screening and outcomes between 2016 and 2020. Risk- factor burden was also compared with cycles 3 to 5 (2012 to 2017) of the Canadian Health Measures Survey (CMHS), which included 9473 participants across Canada.ResultsMean age of our study cohort was 47.9 ± 17.0 years, and 52.0% were women. Lipid and diabetes assessment rates among individuals 40 to 79 years were 76.6% and 78.2%, respectively, and lowest among men 40 to 49 years of age. Total cholesterol levels and diabetes and hypertension rates among men and women 20 to 79 years were similar to Canadian Health Measures Survey (CHMS) findings (total cholesterol: 4.80/4.98 vs 4.94/5.25 mmol/L; diabetes: 8.2%/7.1% vs 8.1%/6.0%; hypertension: 21.4%/21.6% vs 23.9%/23.1%, respectively); however, patients in the CANHEART study had slightly higher mean glucose (men: 5.79 vs 5.44; women: 5.39 vs 5.09 mmol/L) and systolic blood pressures (men: 126.2 vs 118.3; women: 120.6 vs 115.7 mm Hg).ConclusionsCardiovascular health surveillance is possible through linkage of routinely collected electronic population-based datasets. However, further investigation is needed to understand differences between health administrative and survey measures cross-sectionally and over time. 相似文献
6.
7.
8.
9.
10.
《Clinical therapeutics》2022,44(3):403-417.e6
PurposeEntecavir (ETV) and tenofovir disoproxil fumarate (TDF) are both recommended as first-line treatments for patients with chronic hepatitis B virus (CHB) infection according to international HBV treatment guidelines. However, recent studies reported conflicting results regarding the preferred antiviral in the prevention of hepatocellular carcinoma (HCC). This cohort study aimed to investigate this issue by using Taiwan's National Health Insurance Research Database, wherein a “finite” but not life-long treatment policy was applied.MethodsFrom January 2008 to December 2013, a total of 12,388 consecutive adult patients with CHB who received a finite course of TDF treatment (n = 1250) or ETV treatment (n = 11,138) were analyzed through screening for study eligibility followed by the 1:4 propensity score matching method.FindingsIn the entire cohort, the annual incidence and survival between the ETV and TDF groups were not significantly different regarding HCC occurrence (2.05 vs 2.74 per 100 patient-years [PY]; P = 0.055; hazard ratio [HR], 0.975; log-rank, P = 0.966), cirrhosis-related complications (1.9 vs 2.4 per 100 PY; P = 0.149; HR, 0.869; log-rank, P = 0.388), or all-cause mortality (2.16 vs 1.6 per 100 PY; P = 0.119; HR, 0.831; log-rank, P = 0.342), respectively. Propensity score matching analyses yielded similar results regarding HCC occurrence, cirrhosis-related complications, and all-cause mortality. In addition, these findings were consistently reproduced in the subgroups of patients with chronic hepatitis and cirrhosis that developed before antiviral treatment.ImplicationsETV and TDF did not significantly differ in prevention of HCC occurrence or reduction of cirrhosis-related complications and all-cause mortality in patients with CHB receiving a finite period of treatment. 相似文献